Reply to: Cognitive Effects of Deep Brain Stimulation in GBA-Related Parkinson's Disease

Affiliations

¹ Department of Neurology, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ.
² Department of Neurological Sciences, Rush University Medical Center, Chicago, IL.
³ Sorbonne Université, Assistance Publique Hôpitaux de Paris, Inserm, CNRS, Institut du Cerveau - Paris Brain Institute - ICM, Pitié-Salpêtrière Hospital, Department of Neurology, Centre d'Investigation Clinique Neurosciences, Paris, France.
⁴ Parkinson's Disease Clinic, Office of the Clinical Director, NIH/NINDS, Bethesda, MD.
⁵ Department of Neurology, Mount Sinai Beth Israel, Icahn School of Medicine at Mount Sinai, NY, New York.
⁶ Department of Neurology, College of Physicians and Surgeons, Columbia University Medical Center, New York, NY.
⁷ Department of Neurology, St. Olavs Hospital and Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway.
⁸ Robert Wood Johnson Medical School Institute for Neurological Therapeutics, Rutgers Biomedical and Health Sciences, Piscataway, NJ.
⁹ Department of Neurosurgery, Rush University Medical Center, Chicago, IL.
¹⁰ Department of Neurology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands.
¹¹ Department of Clinical & Movement Neurosciences, UCL Institute of Neurology, London, UK.

Comment

Gian Pal et al. Ann Neurol. 2022 Aug.

. 2022 Aug;92(2):345-346.

doi: 10.1002/ana.26433. Epub 2022 Jun 30.

¹ Department of Neurology, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ.
² Department of Neurological Sciences, Rush University Medical Center, Chicago, IL.
³ Sorbonne Université, Assistance Publique Hôpitaux de Paris, Inserm, CNRS, Institut du Cerveau - Paris Brain Institute - ICM, Pitié-Salpêtrière Hospital, Department of Neurology, Centre d'Investigation Clinique Neurosciences, Paris, France.
⁴ Parkinson's Disease Clinic, Office of the Clinical Director, NIH/NINDS, Bethesda, MD.
⁵ Department of Neurology, Mount Sinai Beth Israel, Icahn School of Medicine at Mount Sinai, NY, New York.
⁶ Department of Neurology, College of Physicians and Surgeons, Columbia University Medical Center, New York, NY.
⁷ Department of Neurology, St. Olavs Hospital and Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway.
⁸ Robert Wood Johnson Medical School Institute for Neurological Therapeutics, Rutgers Biomedical and Health Sciences, Piscataway, NJ.
⁹ Department of Neurosurgery, Rush University Medical Center, Chicago, IL.
¹⁰ Department of Neurology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands.
¹¹ Department of Clinical & Movement Neurosciences, UCL Institute of Neurology, London, UK.

No abstract available

Conflict of interest statement

Potential conflicts of interest: none.

Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers.
Pal G, Mangone G, Hill EJ, Ouyang B, Liu Y, Lythe V, Ehrlich D, Saunders-Pullman R, Shanker V, Bressman S, Alcalay RN, Garcia P, Marder KS, Aasly J, Mouradian MM, Link S, Rosenbaum M, Anderson S, Bernard B, Wilson R, Stebbins G, Nichols WC, Welter ML, Sani S, Afshari M, Verhagen L, de Bie RMA, Foltynie T, Hall D, Corvol JC, Goetz CG. Pal G, et al. Ann Neurol. 2022 Mar;91(3):424-435. doi: 10.1002/ana.26302. Epub 2022 Jan 25. Ann Neurol. 2022. PMID: 34984729 Free PMC article.
Cognitive Effects of Deep Brain Stimulation in GBA-Related Parkinson Disease.
Weill C, Gallant A, Lintsky E, Dienstag A, Israel Z, Arkadir D. Weill C, et al. Ann Neurol. 2022 Aug;92(2):344-345. doi: 10.1002/ana.26432. Epub 2022 Jul 1. Ann Neurol. 2022. PMID: 35686430 No abstract available.

1. Weill CG, A; Lintsky E; Dienstag A; Israel Z; Arkadir D Cognitive effects of deep brain stimulation in GBA-related Parkinson’s disease. Annals of Neurology. 2022. - PubMed
1. Parkinson Progression Marker I. The Parkinson Progression Marker Initiative (PPMI). Prog Neurobiol. 2011. Dec;95(4):629–35. - PMC - PubMed
1. Almaghlouth I, Pullenayegum E, Gladman DD, Urowitz MB, Johnson SR. Propensity Score Methods in Rare Disease: A Demonstration Using Observational Data in Systemic Lupus Erythematosus. The Journal of Rheumatology. 2021;48(3):321–5. - PubMed
1. D’Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998. Oct 15;17(19):2265–81. - PubMed
1. Salles PA, Mata IF, Fernandez HH. Should we start integrating genetic data in decision-making on device-aided therapies in Parkinson disease? A Point of View. Parkinsonism & Related Disorders. 2021 2021/May/18/. - PubMed